Trials / Unknown
UnknownNCT02639585
Efficacy and Safety of Daclatasvir Plus Asunaprevir in Chronic Hepatitis C
Efficacy and Safety of Daclatasvir Plus Asunaprevir Treatment in Patients With Chronic Hepatitis C : Prospective Cohort Study
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- Sponsor
- Pusan National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
We perform this study to identity efficacy and safety of Daclatasvir and Asunaprevir in real practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Daclinza and Sunvepra | direct acting antiviral agent against to hepatitis C virus |
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2017-02-01
- Completion
- 2017-06-01
- First posted
- 2015-12-24
- Last updated
- 2015-12-28
Locations
2 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02639585. Inclusion in this directory is not an endorsement.